10-QPeriod: Q2 FY2025

MICROCHIP TECHNOLOGY INC Quarterly Report for Q2 Ended Sep 30, 2024

Filed November 5, 2024For Securities:MCHPMCHPP

Summary

Microchip Technology Inc. (MCHP) reported a significant decline in net sales for the three and six months ended September 30, 2024, compared to the same periods in the prior year. This downturn is primarily attributed to adverse macroeconomic conditions, including slowing economic activity, persistent inflation, and higher interest rates, which have led customers to reduce their inventory levels. Despite the revenue challenges, the company maintained a healthy gross profit margin of 57.4% for the quarter and 58.4% for the six months. Operating expenses, particularly R&D and SG&A, saw decreases due to lower employee compensation costs, contributing to a more efficient operational structure. The company also managed its liquidity well, with substantial cash reserves and positive cash flow from operations, though it noted a decrease in overall cash and cash equivalents. Management has adjusted capital expenditure plans downwards due to the weaker economic environment, indicating a cautious approach to future investments. Key financial highlights include a substantial drop in net sales year-over-year, alongside a considerable decrease in operating income. However, the company is actively managing its inventory and has paused factory expansion efforts to align with current business conditions. The balance sheet shows a decrease in total assets and total liabilities, with a notable reduction in long-term debt. Investors should monitor the impact of ongoing macroeconomic headwinds and the company's ability to navigate inventory adjustments and return to revenue growth.

Financial Statements
Beta
Revenue$1.16B
Cost of Revenue$495.30M
Gross Profit$668.50M
R&D Expenses$240.70M
SG&A Expenses$157.00M
Operating Expenses$521.90M
Operating Income$146.60M
Interest Expense$59.10M
Net Income$78.40M
EPS (Basic)$0.15
EPS (Diluted)$0.14
Shares Outstanding (Basic)536.70M
Shares Outstanding (Diluted)542.00M

Key Highlights

  • 1Net sales decreased significantly by 48.4% for the three months and 47.1% for the six months ended September 30, 2024, compared to the prior year, driven by macroeconomic headwinds and customer inventory reduction.
  • 2Gross profit margin remained relatively strong, at 57.4% for the quarter and 58.4% for the six months, indicating resilient pricing power and cost management despite lower sales volumes.
  • 3Operating income saw a substantial decline, decreasing from $885.0 million in Q3 FY23 to $146.6 million in Q3 FY24 for the three-month period, and from $1,788.1 million to $365.7 million for the six-month period.
  • 4Research and Development (R&D) and Selling, General & Administrative (SG&A) expenses decreased year-over-year, primarily due to lower employee compensation costs, indicating improved operational efficiency.
  • 5The company issued $1.25 billion in 2024 Senior Convertible Debt and entered into corresponding capped call option transactions, influencing its debt structure and future dilution potential.
  • 6Cash flow from operating activities was $420.7 million for the six months ended September 30, 2024, demonstrating continued operational cash generation, albeit lower than the $1,609.4 million in the prior year.
  • 7Total assets decreased to $15,622.3 million as of September 30, 2024, from $15,873.2 million at March 31, 2024, alongside a reduction in total liabilities.

Frequently Asked Questions